Michael Bristow
19Patents
5h-index
16Co-inventors
63Inventor score
Filing activity: Mar 25, 1998 → Feb 8, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6706686B2 | Inhibition of histone deacetylase as a treatment for cardiac hypertrophy | Human Necessities | 45 | Expired |
| US6946441B2 | Inhibition of histone deacetylase as a treatment for cardiac hypertrophy | Human Necessities | 32 | Expired |
| US7678824B2 | Methods for treatment with bucindolol based on genetic targeting | Physics | 10 | Active |
| US5998458A | Method of treating heart failure | Human Necessities | 7 | Expired |
| US8946284B2 | Methods and compositions involving (S)-bucindolol | Human Necessities | 6 | Active |
| US9446023B2 | Methods and compositions involving (S)-bucindolol | Human Necessities | 4 | Active |
| US6167361A | Racing vehicle four-link configuration method and apparatus | Performing Operations; Transporting | 4 | Expired |
| US8093286B2 | Methods for treatment with bucindolol based on genetic targeting | Physics | 4 | Active |
| US6203776A | Method for identifying adrenergic receptor antagonists having good tolerability | Physics | 3 | Expired |
| US9763916B2 | Methods and compositions involving (S)-bucindolol | Human Necessities | 3 | Active |
| US7482331B1 | Diagnosis and treatment of myocardial failure | Chemistry; Metallurgy | 1 | Expired |
| US7049066B2 | Diagnosis and treatment of myocardial failure | Chemistry; Metallurgy | 1 | Expired |
| US8080578B2 | Methods for treatment with bucindolol based on genetic targeting | Physics | 1 | Active |
| US10925856B2 | Methods and compositions involving bucindolol for the treatment of atrial fibrillation | Physics | 0 | Active |
| US8916603B2 | Methods for treatment with bucindolol based on genetic targeting | Physics | 0 | Active |
| US9512481B2 | Polymorphisms in the PDE3A gene | Chemistry; Metallurgy | 0 | Active |
| US6218597A | Transgenic model and treatment for heart disease | Chemistry; Metallurgy | 0 | Expired |
| US11452712B2 | Methods and compositions involving (S)-bucindolol | Human Necessities | 0 | Active |
| US11554107B2 | Methods and compositions involving bucindolol for the treatment of atrial fibrillation | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.